Latest News

FDA announces safety monitoring measures for the essure device

(HealthDay)—The U.S. Food and Drug Administration is implementing a number of steps for long-term safety monitoring of the permanent birth control device Essure, which will no longer be sold or distributed in the United States after Dec. 31, 2018.

Source link

Related posts

STAT Plus: At JPM, a debate on Alzheimer’s disease, some family drama in oncology, and a beaten-down biotech


Hydrogel Harvests Nitric Oxide to Stop Damage from Rheumatoid Arthritis


Parkinson’s Disease Facts Your Doctor Is Not Telling You


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy